Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Methodology|Interests|Funding|Corrections
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Bibliographic record

Stability of protein pharmaceuticals: an update

Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Pharmaceutical Research 2010

Document identifier
CEI-BR-070
Series
Bibliographic record
Version
1.0
Published
30 Jul 2026
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Bibliographic record

§1.1Record

Authors
Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS
Title
Stability of protein pharmaceuticals: an update
Source
Pharmaceutical Research
Year
2010
Volume, issue, pages
27(4):544–575
Digital object identifier
10.1007/s11095-009-0045-6
PubMed identifier
20143256
Record type
Journal article
Institute identifier
CEI-BR-070

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

DocumentSeries
Monograph: ExenatideCompound monograph
Monograph: PramlintideCompound monograph
Monograph: TeduglutideCompound monograph
Monograph: TesamorelinCompound monograph
Monograph: CJC-1295Compound monograph
Monograph: HexarelinCompound monograph
Monograph: GHRP-6Compound monograph
Monograph: Thymosin beta-4Compound monograph
Monograph: GHK-CuCompound monograph
Monograph: SemaxCompound monograph
Monograph: SelankCompound monograph
Monograph: DSIPCompound monograph
Monograph: Thymosin alpha-1Compound monograph
Monograph: LL-37Compound monograph
Monograph: MOTS-cCompound monograph
Monograph: GlutathioneCompound monograph
Monograph: PT-141 (bremelanotide)Compound monograph
Monograph: Kisspeptin-10Compound monograph
Monograph: GonadorelinCompound monograph
Standard CEI-MS-04: Determination of water content in lyophilised peptides by coulometric…Methodological standard
Standard CEI-MS-07: Sub-visible particulate matter in reconstituted peptide solutionsMethodological standard
Standard CEI-MS-11: Determination of aggregate content by size-exclusion chromatographyMethodological standard
Standard CEI-MS-13: Development and validation of a stability-indicating method for…Methodological standard
Standard CEI-MS-09: Assessment of appearance, cake integrity and reconstitution behaviourMethodological standard
Standard CEI-MS-20: Photostability assessment of light-sensitive peptidesMethodological standard
Standard CEI-MS-21: Freeze–thaw and in-use stability assessment of reconstituted peptide…Methodological standard
Synthesis: Reconstitution practice and delivered doseEvidence synthesis
Synthesis: In-use stability of reconstituted peptide solutionsEvidence synthesis
Synthesis: Exenatide in type 2 diabetes mellitus: effect on the anchor outcomeEvidence synthesis
Synthesis: Thymosin alpha-1 in immune modulation and adjunctive immunotherapy…Evidence synthesis
Synthesis: Exenatide in atherosclerotic cardiovascular disease and…Evidence synthesis
Synthesis: Teduglutide in inflammatory bowel disease and mucosal barrier…Evidence synthesis
Synthesis: Thymosin beta-4 in cutaneous wound healing and tissue repair: effect…Evidence synthesis
Synthesis: CJC-1295 in growth hormone deficiency and growth-hormone secretagogue…Evidence synthesis
Synthesis: GHK-Cu in cutaneous wound healing and tissue repair: effect on the…Evidence synthesis
Synthesis: Gonadorelin in growth hormone deficiency and growth-hormone…Evidence synthesis
Synthesis: Kisspeptin-10 in growth hormone deficiency and growth-hormone…Evidence synthesis
Synthesis: PT-141 (bremelanotide) in hypoactive sexual desire and erectile…Evidence synthesis
Synthesis: Semax in cognitive performance and neuroprotection: effect on the…Evidence synthesis
Synthesis: Tesamorelin in hiv-associated lipodystrophy and excess visceral…Evidence synthesis
Synthesis: Exenatide in type 2 diabetes mellitus: tolerability and…Evidence synthesis
Synthesis: Thymosin alpha-1 in immune modulation and adjunctive immunotherapy…Evidence synthesis
Synthesis: Exenatide in atherosclerotic cardiovascular disease and…Evidence synthesis
Synthesis: Teduglutide in inflammatory bowel disease and mucosal barrier…Evidence synthesis
Synthesis: Thymosin beta-4 in cutaneous wound healing and tissue repair…Evidence synthesis
Synthesis: CJC-1295 in growth hormone deficiency and growth-hormone secretagogue…Evidence synthesis
Synthesis: GHK-Cu in cutaneous wound healing and tissue repair: tolerability and…Evidence synthesis
Synthesis: Gonadorelin in growth hormone deficiency and growth-hormone…Evidence synthesis
Synthesis: Kisspeptin-10 in growth hormone deficiency and growth-hormone…Evidence synthesis
Synthesis: PT-141 (bremelanotide) in hypoactive sexual desire and erectile…Evidence synthesis
Synthesis: Semax in cognitive performance and neuroprotection: tolerability and…Evidence synthesis
Synthesis: Tesamorelin in hiv-associated lipodystrophy and excess visceral…Evidence synthesis
Synthesis: Exenatide in type 2 diabetes mellitus: durability of effectEvidence synthesis
Synthesis: Thymosin alpha-1 in immune modulation and adjunctive immunotherapy…Evidence synthesis
Synthesis: Exenatide in atherosclerotic cardiovascular disease and…Evidence synthesis
Synthesis: Teduglutide in inflammatory bowel disease and mucosal barrier…Evidence synthesis
Synthesis: Thymosin beta-4 in cutaneous wound healing and tissue repair…Evidence synthesis
Synthesis: CJC-1295 in growth hormone deficiency and growth-hormone secretagogue…Evidence synthesis
58 citing documents.

§1.3Subject tags

stability formulation review

Compound Evidence Institute · CEI-BR-070 · https://compoundevidence.com/bibliography/manning2010/ · retrieved 30 July 2026
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.